This year ISPOR is implementing new procedures for Board selection. The Society has updated its approach for selecting Board members moving to an uncontested elections process. The Nominations Committee has named a slate of candidates, one for each open Director position. The Board will choose the President-elect and Treasurer based on recommendations from the Nominations Committee. You can read more about the new process here.
The Nominations Committee develops a pool of candidates for board service based on several criteria, including how they best characterize ISPOR’s strategy, represent their organizations’ membership and enhance ISPOR’s commitment to diverse representation, which is inclusive of geography, organization type, gender, geography, and areas of expertise.
We are pleased to share that the following slate of Director nominees will be formally presented to the membership for ratification on March 1
Director 1
Sandra Nestler-Parr, MSc, MPhil, PhD
Senior Vice President, Value & Patient Access
BioCryst Pharmaceuticals
Durham, NC, USA
Director 2
William Padula, PhD
Associate Professor, University of Southern CA
Los Angeles, CA, US
ISPOR Bylaws provide the opportunity for additional nominees to be proposed through a petition process. Petition candidates must meet qualifications for Board service. Members interested in the petition process should contact governance@ispor.org no later than January 19, 2026. Members proposed by petition must be endorsed by at least 10% of the ISPOR voting membership no later than February 15, 2026.